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ABSTRACT 
Psoriasis is defined as a type of severe inflammatory and autoimmune skin disease, caused due to genetic and 
natural/surrounding factors and the most successful way to tackle this disease is topical treatment. To examine potency 
of the herbal drug in the cure of psoriasis like lesions on mice skin is the core objective of this study. Imiquimod model 
of psoriasis was used in the evaluation of the drug and the qRT-PCR was done to check cytokines concentration in the 
blood serum of psoriasis induced mice. The drug karanjin oil was proved to have anti-psoriatic activity.  
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INTRODUCTION: 
Psoriasis is non curable, non contagious, itchy and 
painful disease. Clinical features are scaling and 
redness
1
. The cause is not known still but studies say 
that it is due to some genetic factor or immunological 
factors or biochemical process which regulates the 
proliferation and development of upper skin cells. 
Following factors aggravates psoriasis mental stress, 
more alcohol consumption, smoking etc
2
. 
Epidemiology 
2-3% of world population is affected by Psoriasis. It 
occurs in both male and female. It is reported at birth as 
well as in old age and mainly seen in western countries. 
In India especially north india, males are more prone to 
psoriasis than female mainly in the age group between 
30 yrs to 40 yrs of age. 
Types of Psoriasis 
1. Plaque psoriasis- Most general type of psoriasis 
characterized by swollen red scaly bumps covered 
with silvery white scales. 
2. Guttate- Next common type of psoriasis after 
plaque psorisis, mainly seen in younger generations, 
characterized by small red spots. 
3. Inverse- It is characterized by red non- scaly and 
shiny patch in the skin folds. 
4. Pustular- It is a rare type of psoriasis. It mainly 
occurs in adults, characterized by raised pus filled 
bumps. 
5. Erythrodemic- Rarest and most unsafe type of 
psoriasis characterized by red, crusty, pustular 
bumps all over the body. 
6. Nail psoriasis- 50% of psoriasis patient have nail 
psoriasis, characterized by yellowish brown nails 
with gap between nail bed due to deposition of 
chalky material. Mainly seen in psoriatic arthritis 
patient. 
7. Psoriatic arthritis- It is a type of disease in which 
patient is suffering from psoriasis as well as joint 
inflammation
3
. 
Pathophysiology 
Being a T cell mediated disease that is characterized by 
uncontrolled scaling along with redness, pain and 
angiogenesis. The CD4+T cells stimulated the disease 
by complexing with antigen-presenting cells in the skin, 
which provokes the CD8+ T cells in the epidermis. This 
complex between CD4+ T cells, CD8+ T, dendritic cell 
and keratinocytes gives rise to cytokine soup which 
mainly consists of T helper cell type cytokins such as 
IL-1β, IL-12, IFN-γ and TNF-α. Thus the cytokines acts 
as biomarkers in the pathophysiology of psoriasis
4
. 
Treatment 
Topical Therapy includes corticosteroids, anthralin etc, 
Systemic agents includes Cyclosporine etc, 
phototherapy includes PUVA, UVB; Herbal treatment 
and Homeopathic treatment. 
Marketed Drugs 
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Zoratame (25 mg), Silrox, Lobate-M, Graftin(25mg, 
100mg), Dosetil, Resol  and Vit. D derivatives etc. 
Models used in the study of Psoriasis
5
 
1. Spontaneous mutation 
2. Genetically engineered rodents 
3. Immunological reconstitution approach 
4. Xenotransplantation 
5. Imiquimod Model 
qRT-PCR 
The level of cytokinin was measured by PCR. 
Application of Drug (Karanjin oil) 
Once the physiological parameters confirmed the 
successful induction of psoriasis like lesions on the 
mice. The oil was applied on the lesions of the standard 
group and at the same time vanishing cream on the 
lesions of the test everyday for 1 week. 
Cytokine measurement  
After 8 days, blood samples from the lesions of mice of 
all the groups were taken and on them PCR was 
performed to check the concentration of cytokines (IL-
1β, IL-12, IFN-γ and TNF-α) in the mice blood. 
RESULTS AND DISCUSSION: 
PCR Test 
Inflammatory mediators like cytokines act as Biomarker 
in the pathophysiology of Psoriasis. The levels of 
cytokines were checked in both controlled and standard. 
As shown in the Table, it was observed that the levels of 
IL-1β, IL-12, IFN-γ and TNF-α was less and close to 
normal in the test and that of controlled and standard 
was very high. 
 
Table 1: Cytokine level in standard, control and test group 
Cytokine (pg/ml) Standard group  Control group   Test group 
IL-1β 305.02±11.67 312.32±9.65 130.20±17.00 
IL-12 89.43±17.77 95.21±14.98 76.04±10.00 
IFN-γ 32.87±9.01 35.88±8.29 25.07±2.05 
TNF-α 934.66±155.35 978±145.33 578.22±107.66 
All value represents the mean as well as S.D. (n = 6). 
CONCLUSION: 
During the study of Karanjin it was found that it gives the positive results and it was established that karanjin cured the 
psoriasis like lesions on mice skin which was induced by imiquimod. 
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